Clinical Trials Logo

Acquired Blepharoptosis clinical trials

View clinical trials related to Acquired Blepharoptosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT02436759 Completed - Clinical trials for Acquired Blepharoptosis

Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis

Start date: May 2015
Phase: Phase 3
Study type: Interventional

This is a Phase 3 study is to evaluate the safety and efficacy of RVL-1201 Ophthalmic Solution in the treatment of acquired blepharoptosis (ptosis) and to assess the safety and comfort of RVL-1201 Ophthalmic Solution for an extended dosing period of 6 weeks.